Coronavirus updates: 84% of California population to go on lockdown Sunday night

More than 33 million people in the state will be affected by the lockdown.

Last Updated: December 7, 2020, 8:34 AM EST

A pandemic of the novel coronavirus has now infected more than 66.4 million people and killed over 1.5 million worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.

Latest headlines:

Here's how the news developed this week. All times Eastern.
Dec 04, 2020, 11:35 AM EST

COVID-19 appears to be 3rd leading cause of death in US

COVID-19 will probably be ranked at least third for leading causes of death in the U.S. this year, Bob Anderson, Chief, Mortality Statistics Branch at National Center for Health Statistics, told ABC News.

"We won’t make that determination officially until all the data are in," Anderson added.

People come to be tested for COVID-19 at a test site in a parking lot at Bergen Community College run by Bergen County and the Bergen New Bridge Medical center on Dec. 3, 2020 in Paramus, N.J.
David Dee Delgado/Getty Images

The No. 1 cause of death is heart disease, with 655,381 deaths, followed by cancer with 599,274 deaths, according to CDC data.

COVID-19 is in the No. 3 spot with 276,513 fatalities, followed by accidents which accounted for 167,127 deaths, according to the CDC.

-ABC News' Eric Strauss

Dec 04, 2020, 10:09 AM EST

Africa aims to vaccinate 60% of population in 2-3 years

Africa aims to have 60% of its 1.2 billion-strong population vaccinated against COVID-19 within the next two to three years, according to the head of the continent's public health agency.

"We hope that for that for this to be meaningful, our 60% must be reached in the next two to three years," John Nkengasong, director of the Africa Centers for Disease Control and Prevention, said at a press briefing Thursday. "We should be deliberate in this."

More than 2.2 million confirmed cases of COVID-19, including over 52,000 deaths, have been reported across the vast continent so far, representing a fraction of the world's cumulative count.

Dec 04, 2020, 8:59 AM EST

Moscow launches mass COVID-19 vaccination program

Moscow Mayor Sergey Sobyanin announced Friday the official start of a mass COVID-19 vaccination program in the Russian capital.

Residents are now able to sign up online to be vaccinated, and Sobyanin said some 5,000 people had registered in the first five hours since the launch.

"Teachers, doctors, social workers, those who today most of all risk their health and lives," the mayor wrote in a brief post on his blog Friday.

The announcement comes two days after Russian President Vladimir Putin unexpectedly ordered large-scale vaccination to start next week, despite earlier statements from the government saying the country has yet to produce enough vaccine doses to do so.

Pedestrians and an electronic screen displaying epidemic prevention advice are reflected in a glass wall in Moscow, Russia, on Dec. 3, 2020, amid the coronavirus pandemic.
Dimitar Dilkoff/AFP via Getty Images

The mass inoculation campaigns will use Russia’s COVID-19 vaccine, called Sputnik V, which the health ministry controversially registered in August before starting crucial late-stage clinical trials. Vaccinations will be voluntary, with the drives first focusing on teachers and doctors.

Russia was still vaccinating volunteers as part of its phase 3 trial, which has so far only managed to inoculate 20,000 of a planned 40,000 people.

Putin has said that Russia will soon produce 2 million doses of Sputnik V, but it's unclear how many doses have been been produced so far and how many people will be able to be vaccinated from next week. The country has run into serious manufacturing hurdles and had to significantly cut its planned production from 30 million to 2 million by the end of the year.

ABC News' Patrick Reevell contributed to this report.

Dec 04, 2020, 7:31 AM EST

COVID-19 vaccinations will be free of charge in France

French Prime Minister Jean Castex said COVID-19 vaccinations will not be made compulsory but "will be free for all" in the country's social security system.

"Getting a vaccine is also about protecting others. It is a choice of trust, we must be as numerous as possible to get a vaccine," Castex said at a press conference Thursday evening, while unveiling the country's vaccination strategy.

France will launch a COVID-19 vaccination campaign within weeks, pending regulatory approval by the European Medicines Agency. The program will run throughout 2021, staggered over three categories of people.

PHOTO: This photograph taken on Dec. 3, 2020 shows empty beds at the Polyclinique Jean Villar private hospital in Bruges, southwestern France, as a television broadcasts a press conference with French Prime Minister Jean Castex.
This photograph taken on Dec. 3, 2020 shows empty beds at the Polyclinique Jean Villar private hospital in Bruges, southwestern France, as a television broadcasts a press conference with French Prime Minister Jean Castex, who is outlining the country's strategy for the deployment of future COVID-19 vaccines.
Philippe Lopez/AFP via Getty Images

The first phase is slated to begin in January, with vaccines administered to nursing home residents and staff, representing 1 million people. A second phase starting in February will see 14 million people inoculated, based on age and medical criteria. The third and final phase, beginning in March, will target the remainder of the population who wish to be vaccinated.

Through deals clinched by the European Union, France has secured some 200 million doses of COVID-19 vaccines from several pharmaceutical companies and biotechnology firms that developed them and have applied for temporary authorization. Castex said that's enough doses to inoculate 100 million people -- more than France's entire population.

As of Friday afternoon, France's health ministry had confirmed a total of 2,257,331 cases of COVID-19 since the start of the pandemic, including 54,140 deaths.

ABC News' Ibtissem Guenfoud contributed to this report.

Related Topics